Search results
Results from the WOW.Com Content Network
Polycystic ovary syndrome, or polycystic ovarian syndrome (PCOS), is the most common endocrine disorder in women of reproductive age. [14] The syndrome is named after cysts which form on the ovaries of some women with this condition, though this is not a universal symptom, and not the underlying cause of the disorder.
Not all women with PCOS have difficulty becoming pregnant. For those who do, anovulation is a common cause. The mechanism of this anovulation is uncertain, but there is evidence of arrested antral follicle development, which, in turn, may be caused by abnormal interaction of insulin and luteinizing hormone (LH) on granulosa cells.
Some studies report a higher incidence of polycystic ovary syndrome (PCOS) among transgender men prior to taking testosterone, [78] [79] [80] the disease causes infertility and can make it harder for trans men to freeze eggs, [81] though not all have not found the same association of trans men and PCOS. [82]
The hormones in the pill have also been used to treat other medical conditions, such as polycystic ovary syndrome (PCOS), endometriosis, adenomyosis, acne, hirsutism, amenorrhea, menstrual cramps, menstrual migraines, menorrhagia (excessive menstrual bleeding), menstruation-related or fibroid-related anemia and dysmenorrhea (painful menstruation).
Ricardo Azziz is a Uruguayan-American higher education and biomedical executive administrator and researcher who serves as Principal of SPH Consulting Group. [1] [2] He also serves as Executive Director of the non-profit Foundation for Research and Education Excellence [3] and Director of the Center for Higher Education Mergers and Acquisitions at the Foundation.
PCOS: Polycystic Ovary Syndrome (PCOS) is one disease that higher levels of α-lactalbumin have been linked with relieving symptoms. This condition is closely linked with gut dysbiosis caused by inflammation of the intestinal lining and a microbiota imbalance. α-Lactalbumin promotes healthy bacterial strains such as Lactobacillus acidophilus ...
Retatrutide (LY-3437943) is an experimental drug for obesity developed by American pharmaceutical company Eli Lilly and Company.It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors). [1]
This page is the list of featured articles that were promoted in 2023, ... April 26, 2023: Bobamnertiopsis: 2022 World Snooker Championship: May 1, 2023: